EcoDrugPlus

Tubulin Alpha 3c

Ensembl ID : ENSMPUG00000003660
Gene Symbol: TUBA3C
4 Cross references
213 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMPUG00000016605
Gene Symbol: TUBA4A
2 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMPUG00000007062
Gene Symbol: TUBB1
2 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSMPUG00000000462
Gene Symbol: TUBB2B
4 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMPUG00000006991
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMPUG00000006958
Gene Symbol: TUBB4A
2 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMPUG00000015115
Gene Symbol: TUBB4B
2 Cross references
317 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMPUG00000004505
Gene Symbol: TUBB6
2 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMPUG00000011690
Gene Symbol: TUBB
2 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMPUG00000009017
Gene Symbol: TP53
2 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMPUG00000010381
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSMPUG00000005628
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).